CVS Group plc (LON:CVSG)
London · Delayed Price · Currency is GBP · Price in GBX 1,170.00
+17.00 (1.47%)
May 19, 2026, 4:37 PM GMT
CVS Group Market Cap
CVS Group has a market cap or net worth of 820.83 million as of May 19, 2026. Its market cap has decreased by -10.89% in one year.
Market Cap
820.83M
Enterprise Value
1.09B
Revenue
692.80M
Ranking
n/a
PE Ratio
51.09
Stock Price
1,170.00
Market Cap Chart
Since October 10, 2007, CVS Group's market cap has increased from 4.71M to 820.83M, an increase of 17,316.73%. That is a compound annual growth rate of 31.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 820.83M | -9.59% |
| Dec 31, 2025 | 907.93M | 50.66% |
| Dec 31, 2024 | 602.62M | -49.95% |
| Dec 29, 2023 | 1.20B | -12.67% |
| Dec 30, 2022 | 1.38B | -13.16% |
| Dec 31, 2021 | 1.59B | 49.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.64B |
| GSK plc | 74.91B |
| Haleon | 29.87B |
| Smith & Nephew | 9.58B |
| Genus | 1.58B |
| Oxford Nanopore Technologies | 1.17B |
| Spire Healthcare Group | 889.33M |
| Oxford Biomedica | 736.41M |